ADAMANTYL-THPINACA is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was first discovered in Slovenia as part of a seizure of 746 g of white powder and 2 kg of brown/green plant material in October 2014.


== Legal status ==
ADAMANTYL-THPINACA is banned in Sweden.


== See also ==


== References ==